LORD, ABBETT & CO. LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 130 filers reported holding ENDOLOGIX INC in Q4 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2016$4,886,000
+4.1%
381,737
+1.3%
0.02%0.0%
Q2 2016$4,694,000
-77.2%
376,731
-81.9%
0.02%
-75.8%
Q4 2015$20,593,000
+124.4%
2,080,100
+177.9%
0.06%
+121.4%
Q3 2015$9,178,000
-72.6%
748,616
-65.7%
0.03%
-68.2%
Q2 2015$33,485,000
+3500.5%
2,182,899
+2389.1%
0.09%
+4300.0%
Q3 2014$930,000
-98.1%
87,699
-96.9%
0.00%
-98.1%
Q4 2013$48,570,000
+34.8%
2,784,967
+24.7%
0.11%
+30.1%
Q3 2013$36,037,000
+236.6%
2,234,189
+177.2%
0.08%
+232.0%
Q2 2013$10,705,000806,1060.02%
Other shareholders
ENDOLOGIX INC shareholders Q4 2015
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$62,127,0007.14%
Essex Woodlands Management, Inc. 1,257,468$24,875,0004.49%
First Light Asset Management, LLC 304,602$4,673,0002.20%
ArrowMark Colorado Holdings LLC 3,464,775$53,150,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,449,897$37,581,0001.25%
Iguana Healthcare Management, LLC 200,000$3,068,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,262,0000.71%
PALISADE CAPITAL MANAGEMENT, LP 1,651,798$25,339,0000.64%
PERKINS CAPITAL MANAGEMENT INC 34,200$525,0000.46%
CADIAN CAPITAL MANAGEMENT, LP 967,443$14,841,0000.44%
View complete list of ENDOLOGIX INC shareholders